Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. [electronic resource] by
- Tjoa, B A
- Erickson, S J
- Bowes, V A
- Ragde, H
- Kenny, G M
- Cobb, O E
- Ireton, R C
- Troychak, M J
- Boynton, A L
- Murphy, G P
Producer: 19970930
In:
The Prostate vol. 32
Availability: No items available.
|
|
16.
|
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer. [electronic resource] by
- Murphy, G P
- Troychak, M J
- Cobb, O E
- Bowes, V A
- Kenny, R J
- Barren, R J
- Kenny, G M
- Ragde, H
- Holmes, E H
- Wolfert, R L
Producer: 19971027
In:
The Prostate vol. 33
Availability: No items available.
|
|
17.
|
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. [electronic resource] by
- Tjoa, B A
- Simmons, S J
- Bowes, V A
- Ragde, H
- Rogers, M
- Elgamal, A
- Kenny, G M
- Cobb, O E
- Ireton, R C
- Troychak, M J
- Salgaller, M L
- Boynton, A L
- Murphy, G P
Producer: 19980716
In:
The Prostate vol. 36
Availability: No items available.
|
|
18.
|
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease. [electronic resource] by
- Murphy, G P
- Tjoa, B A
- Simmons, S J
- Jarisch, J
- Bowes, V A
- Ragde, H
- Rogers, M
- Elgamal, A
- Kenny, G M
- Cobb, O E
- Ireton, R C
- Troychak, M J
- Salgaller, M L
- Boynton, A L
Producer: 19990223
In:
The Prostate vol. 38
Availability: No items available.
|